Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has become the standard of care, particularly in patients with acute coronary syndrome (ACS). Current clinical guidelines recommend novel P2Y12 inhibitors (e.g., prasugrel or ticagrelor) in addition to aspirin based on the res...

Full description

Bibliographic Details
Main Authors: Yohei Numasawa, Mitsuaki Sawano, Ryoma Fukuoka, Kentaro Ejiri, Toshiki Kuno, Satoshi Shoji, Shun Kohsaka
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
dual antiplatelet therapy
P2Y12 inhibition
acute coronary syndrome
percutaneous coronary intervention
tailored therapy
Online Access:https://www.mdpi.com/2077-0383/9/6/1963

Internet

https://www.mdpi.com/2077-0383/9/6/1963

Similar Items